Animal‐to‐Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule

Podobne zapisy

• Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity
  od: Yamamoto, Brent J., i wsp.
  Wydane: (2016)
• Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax
  od: Yamamoto, Brent J., i wsp.
  Wydane: (2016)
• Approval of Raxibacumab for the Treatment of Inhalation Anthrax Under the US Food and Drug Administration “Animal Rule”
  od: Tsai, Chia-Wei, i wsp.
  Wydane: (2015)
• Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans
  od: Nagy, Christa F., i wsp.
  Wydane: (2017)
• FDA Experience with Medical Countermeasures under the Animal Rule
  od: Paul Aebersold
  Wydane: (2012-01-01)